Frej Fyhrquist

17.1k citations
228 papers · 12.5k indexed · 2 hit papers · h-index 42

Impact in

Papers in

Frej Fyhrquist

227 papers receiving 11.8k citations

Hit Papers

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol 2002 · 3.9k citations
3.9k200220262010201810002.0k3.0k

Peers

Frej Fyhrquist
Comparison fields: 5 of 157
  • Cardiology and Cardiovascular Medicine 7.5k
  • Endocrinology, Diabetes and Metabolism 3.5k
  • Nephrology 1.2k
  • Aging 190
  • Physiology 1.8k
Replace Reinhold Kreutz with:
Reinhold Kreutz Germany
François Cambien France
A.H. Jan Danser Netherlands
Dimitri P. Mikhailidis United Kingdom
Antonio Salvetti Italy
Raffaele Marfella Italy
Kazuaki Shimamoto Japan
Matthias Barton Switzerland
Agostino Virdis Italy
Satoshi Umemura Japan
Frej Fyhrquist relative to Reinhold Kreutz Germany Reinhold Kreutz's profile →
Citations per field
00.5×2.7×
Reinhold Kreutz · 1×
Citations per year

Countries citing papers authored by Frej Fyhrquist

Since Specialization
Citations

This map shows the geographic impact of Frej Fyhrquist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frej Fyhrquist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frej Fyhrquist more than expected).

Fields of papers citing papers by Frej Fyhrquist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frej Fyhrquist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frej Fyhrquist. The network helps show where Frej Fyhrquist may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Frej Fyhrquist, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frej Fyhrquist Line = papers co-authored together Frej Fyhrquist links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20212
2 2017191
3 200496
4 200132
5 200123
6 19999
7 199817
8 19957
9 199431
10 199411
11 199414
12 199215
13 199130
14 199093
15 19893
16 19891
17 19887
18 198817
19 19872
20
Peptide-binding macromolecules in the blood of seriously ill or mentally retarded patients.
19762

About Frej Fyhrquist

Frej Fyhrquist is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology, Endocrinology, Diabetes and Metabolism, Aging and Developmental Neuroscience, having authored 228 papers that have together received 12.5k indexed citations. Recurring topics across this work include Renin-Angiotensin System Studies (35 papers), Hormonal Regulation and Hypertension (29 papers), Blood Pressure and Hypertension Studies (26 papers), Nitric Oxide and Endothelin Effects (21 papers), Electrolyte and hormonal disorders (21 papers), Heart Failure Treatment and Management (21 papers), Protein Hydrolysis and Bioactive Peptides (17 papers) and Erythropoietin and Anemia Treatment (12 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (7.5k citations), Endocrinology, Diabetes and Metabolism (3.5k citations), Nephrology (1.2k citations), Aging (190 citations) and Physiology (1.8k citations). Frej Fyhrquist has collaborated with scholars based in Finland, Sweden and United States. Frequent co-authors include Richard B. Devereux, Hans Ibsen, Markku S. Nieminen, Per Omvik, Lars Lindholm, Ole Lederballe‐Pedersen, Sverre E. Kjeldsen, Stevo Julius, Ulf dé Fairé and Hans Wedel. Their work appears in journals such as Scandinavian Journal of Clinical and Laboratory Investigation, Journal of Internal Medicine, European Journal of Pharmacology, Blood Pressure and Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026